Gilead Sciences, Inc. Financial Statements — GILD Stock

Income Statement	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	7,011	7,949	8,385	9,702	11,202	24,890	32,639	30,390	26,107	22,127	22,449	24,689	27,305	27,281	27,116
+ Sales & Services Revenue	7,011	7,949	8,385	9,702	11,202	24,890	32,639	30,390	26,107	22,127	22,449	24,689	27,305	27,281	27,116
- Cost of Revenue	1,596	1,870	2,124	2,471	2,859	3,788	4,006	4,261	4,371	4,853	4,675	4,572	6,601	5,657	6,498
+ Cost of Goods & Services	1,596	1,870	2,124	2,471	2,859	3,788	4,006	4,261	4,371	4,853	4,675	4,572	6,601	5,657	6,498
Gross Profit	5,416	6,080	6,261	7,231	8,343	21,102	28,633	26,129	21,736	17,274	17,774	20,117	20,704	21,624	20,618
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	1,887	2,117	2,471	3,221	3,819	5,837	6,440	8,496	7,612	7,976	8,436	10,190	9,847	10,650	11,808
+ Selling, General & Admin	947	1,044	1,242	1,461	1,699	2,983	3,426	3,398	3,878	4,056	4,381	5,151	5,246	5,673	6,090
+ Research & Development	940	1,073	1,229	1,760	2,120	2,854	3,014	5,098	3,734	3,920	4,055	5,039	4,601	4,977	5,718
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	3,529	3,962	3,790	4,010	4,524	15,265	22,193	17,633	14,124	9,298	9,338	9,927	10,857	10,974	8,810
- Non-Operating (Income) Loss	27	49	139	398	316	409	534	536	595	1,499	4,178	8,258	2,579	5,160	1,951
+ Interest Expense, Net	27	49	139	361	307	412	688	964	1,118	1,077	995	984	1,001	935	944
+ Interest Expense	70	109	205	361	307	412	688	964	1,118	1,077	995	984	1,001	935	944
- Interest Income	42	60	67	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	- -	- -	37	9	-3	-154	-428	-523	422	3,183	7,274	1,578	4,225	1,007
Pretax Income	3,502	3,914	3,651	3,612	4,208	14,856	21,659	17,097	13,529	7,799	5,160	1,669	8,278	5,814	6,859
- Income Tax Expense (Benefit)	876	1,024	862	1,038	1,151	2,797	3,553	3,609	8,885	2,339	-204	1,580	2,077	1,248	1,247
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	2,626	2,890	2,789	2,574	3,057	12,059	18,106	13,488	4,644	5,460	5,364	89	6,201	4,566	5,612
- Net Extraordinary Losses (Gains)	-20	-23	-29	-36	-36	-84	-4	-26	32	10	-44	-68	-48	-52	-105
+ Discontinued Operations	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	-20	-23	-29	-36	-36	-84	-4	-26	32	10	-44	-68	-48	-52	-105
Income (Loss) Incl. MI	2,646	2,913	2,818	2,610	3,093	12,143	18,110	13,514	4,612	5,450	5,408	157	6,249	4,618	5,717
- Minority Interest	10	12	15	18	18	42	2	13	-16	-5	22	34	24	26	52
Net Income, GAAP	2,636	2,901	2,804	2,592	3,075	12,101	18,108	13,501	4,628	5,455	5,386	123	6,225	4,592	5,665
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	2,636	2,901	2,804	2,592	3,075	12,101	18,108	13,501	4,628	5,455	5,386	123	6,225	4,592	5,665
Basic Weighted Avg Shares	1,809	1,712	1,550	1,515	1,529	1,522	1,464	1,339	1,307	1,298	1,270	1,257	1,256	1,255	1,248
Basic EPS, GAAP	1.46	1.69	1.81	1.71	2.01	7.95	12.37	10.08	3.54	4.2	4.24	0.1	4.96	3.66	4.54
Basic EPS from Cont Ops	1.45	1.69	1.8	1.7	2	7.92	12.37	10.07	3.55	4.21	4.22	0.07	4.94	3.64	4.5
Diluted Weighted Avg Shares	1,868	1,747	1,580	1,583	1,695	1,647	1,521	1,358	1,319	1,308	1,277	1,263	1,262	1,262	1,258
Diluted EPS, GAAP	1.41	1.66	1.77	1.64	1.81	7.35	11.91	9.94	3.51	4.17	4.22	0.1	4.93	3.64	4.5
Diluted EPS from Cont Ops	1.41	1.65	1.76	1.63	1.8	7.32	11.9	9.93	3.52	4.17	4.2	0.07	4.91	3.62	4.46
EBITDA	3,742	4,228	4,092	4,288	4,869	16,315	23,291	18,791	15,410	10,727	10,742	11,407	12,907	13,077	11,503
EBITDA Margin (%)	53.37	53.18	48.8	44.2	43.47	65.55	71.36	61.83	59.03	48.48	47.85	46.2	47.27	47.93	42.42
EBITA	3,529	3,962	3,790	4,010	4,524	15,265	22,193	17,633	14,124	9,298	9,338	9,927	10,857	10,974	8,810
EBIT	3,529	3,962	3,790	4,010	4,524	15,265	22,193	17,633	14,124	9,298	9,338	9,927	10,857	10,974	8,810
Gross Margin (%)	77.24	76.48	74.67	74.53	74.48	84.78	87.73	85.98	83.26	78.07	79.18	81.48	75.82	79.26	76.04
Operating Margin (%)	50.34	49.84	45.2	41.33	40.39	61.33	68	58.02	54.1	42.02	41.6	40.21	39.76	40.23	32.49
Profit Margin (%)	37.59	36.5	33.43	26.72	27.45	48.62	55.48	44.43	17.73	24.65	23.99	0.5	22.8	16.83	20.89
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	1.28	1.83	2.09	2.29	2.54	2.74	2.87	2.96	3.05
Depreciation Expense	213	265	302	278	345	1,050	1,098	1,158	1,286	1,429	1,404	1,480	2,050	2,103	2,693

Balance Sheet	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	4,813	5,708	13,919	6,156	6,997	17,714	24,762	19,588	31,823	35,836	30,296	15,996	14,772	14,443	16,085
+ Cash, Cash Equivalents & STI	1,657	2,099	9,900	1,862	2,132	10,128	14,607	11,895	25,510	30,089	24,352	7,408	6,520	6,385	7,264
+ Cash & Cash Equivalents	1,273	908	9,884	1,804	2,113	10,027	12,851	8,229	7,588	17,940	11,631	5,997	5,338	5,412	6,085
+ ST Investments	384	1,191	16	59	19	101	1,756	3,666	17,922	12,149	12,721	1,411	1,182	973	1,179
+ Accounts & Notes Receiv	1,390	1,622	1,951	1,751	2,182	4,635	5,854	4,514	3,851	3,327	3,582	4,892	4,493	4,777	4,660
+ Accounts Receivable, Net	1,390	1,622	1,951	1,751	2,182	4,635	5,854	4,514	3,851	3,327	3,582	4,892	4,493	4,777	4,660
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	1,052	1,204	1,390	1,745	1,697	1,386	1,955	1,587	801	814	922	1,683	1,618	1,507	1,787
+ Raw Materials	334	408	698	827	1,049	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	392	455	466	359	413	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	326	341	226	560	593	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	-359	1,386	1,955	1,587	801	814	922	1,683	1,618	1,507	1,787
+ Other ST Assets	714	784	677	798	986	1,565	2,346	1,592	1,661	1,606	1,440	2,013	2,141	1,774	2,374
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	4,886	5,885	3,384	15,083	15,582	16,950	26,954	37,389	38,460	27,839	31,331	52,411	53,180	48,727	46,040
+ Property, Plant & Equip, Net	700	701	774	1,100	1,166	1,674	2,276	2,865	3,295	4,006	4,502	4,967	5,121	5,475	5,317
+ Property, Plant & Equip	1,005	1,018	1,133	1,524	1,668	2,294	3,039	3,683	4,289	5,197	5,924	6,635	7,014	7,661	7,766
- Accumulated Depreciation	305	316	358	423	502	620	763	818	994	1,191	1,422	1,668	1,893	2,186	2,449
+ LT Investments & Receivables	2,248	3,219	64	720	439	1,598	11,601	20,485	11,184	1,423	1,488	502	1,309	1,245	1,163
+ LT Investments	2,248	3,219	64	720	439	1,598	11,601	20,485	11,184	1,423	1,488	502	1,309	1,245	1,163
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	1,938	1,964	2,546	13,263	13,977	13,678	13,077	14,039	23,981	22,410	25,341	46,942	46,750	42,007	39,560
+ Total Intangible Assets	1,525	1,426	2,067	12,797	13,069	12,245	11,419	10,143	21,259	19,855	17,903	41,234	41,787	37,207	34,768
+ Goodwill	1,525	533	1,004	1,061	1,169	1,172	1,172	1,172	4,159	4,117	4,117	8,108	8,332	8,314	8,314
+ Other Intangible Assets	- -	893	1,063	11,736	11,900	11,073	10,247	8,971	17,100	15,738	13,786	33,126	33,455	28,893	26,454
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	413	538	479	466	908	1,433	1,658	3,896	2,722	2,555	7,438	5,708	4,963	4,800	4,792
Total Assets	9,699	11,593	17,303	21,240	22,579	34,664	51,716	56,977	70,283	63,675	61,627	68,407	67,952	63,171	62,125
+ Payables & Accruals	1,743	1,568	2,265	2,761	3,356	4,828	8,088	8,820	8,433	7,302	6,524	7,189	8,668	5,343	5,560
+ Accounts Payable	811	803	1,206	1,327	1,256	955	1,178	1,206	814	790	713	844	705	905	550
+ Accrued Taxes

Gilead Sciences, Inc.

Income Statement

Balance Sheet